Barclays PLC

BCS·NYSE·Financial Services
Compare
22.950.00 (0.00%)today
At close: Oct 9, 4:00 PM EDT · Real-time · USD
After hours22.950.00 (0.00%)Oct 9, 4:00 PM EDT

Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close22.95
Open22.92
Day range22.8022.99
52-week range19.2928.69
Volume4.41M
Avg. volume (3M)4.54M
Market cap76.57B
P/E ratio (TTM)8.86
Forward P/E6.94
EPS (TTM)2.59
Dividend yield2.69% (0.6200)
Beta (5Y)0.91
Shares outstanding3.34B
Earnings dateOct 22, 2026
Analyst target29.92
Profit margin27.87%

Latest news

All BCS news ›
Daily Mail·Downbeat

Ex-trader wrongly convicted of rate rigging set to sue Barclays

By ANGHARAD CARRICK, BUSINESS NEWS EDITOR A former Barclays trader whose conviction for rate rigging was quashed this week plans to sue the bank. Jay Merchant was jailed in 2016 for conspiracy to defraud in connection with the alleged…

The Globe and Mail·

Roth MKM Remains a Buy on Nuvectis Pharma (NVCT)

Detailed price information for Nuvectis Pharma Inc (NVCT-Q) from The Globe and Mail including charting and trades. Roth MKM Remains a Buy on Nuvectis Pharma (NVCT) Roth MKM analyst maintained a Buy rating on Nuvectis Pharma today and set a…

The Globe and Mail·Upbeat

Maxim Group Keeps Their Buy Rating on Nuvectis Pharma (NVCT)

In a report released yesterday, Naz Rahman from Maxim Group reiterated a Buy rating on Nuvectis Pharma, with a price target of $30.00. Rahman covers the Healthcare sector, focusing on stocks such as Nuvectis Pharma, Vertex Pharmaceuticals,…

The Globe and Mail·Upbeat

Barclays Keeps Their Buy Rating on Aegean Airlines (0OHY)

The Globe and Mail Barclays analyst Andrew Lobbenberg maintained a Buy rating on Aegean Airlines on October 8 and set a price target of €14.50. The company’s shares closed yesterday at €10.97. Lobbenberg covers the Industrials sector,…

The Globe and Mail·

J.P. Morgan Sticks to Their Hold Rating for Cleveland-Cliffs (CLF)

In a report released today, Bill Peterson from J.P. Morgan maintained a Hold rating on Cleveland-Cliffs, with a price target of $12.00. According to TipRanks, Peterson is a 4-star analyst with an average return of 6.7% and a 47.97% success…

The Globe and Mail·

Cathie Wood Just Cut Her SpaceX Position. Is It Time to Sell?

Ark Invest estimates a $160 billion market opportunity in reusable rocket launchers. Ark sold a small part of the Next Generation Technology ETF. Famed growth investor Cathie Wood has been a longtime fan of Elon Musk and Space Exploration…

The Motley Fool·

NICE Stock Analysis: Buy or Sell?

A lower price alone is not enough to make a stock a buying opportunity. Investors are curious if this is a value stock or a value trap. Motley Fool Stock Advisor’s Latest Pick Invest better with The Motley Fool. Get stock recommendations,…

The Globe and Mail·

Sangoma Technologies Q3 Earnings Call Highlights

Sangoma Technologies (NASDAQ:SANG) lowered its full-year fiscal 2026 revenue outlook and said its board has launched a structured strategic review, as management described a business increasingly split between growing communications…

From articles in the 4Search news index.

In the news

14,006mentions in 30 days
35with it in the headline
Mixedheadline tone

Measured across the 4Oxnard news index. Headline tone is a simple word-based reading of the latest 120 headlines, not a forecast.

Market data is provided for information only and comes from free public sources. Quotes are marked real-time or delayed as their source reports them; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Oxnard index. Terms of use.